Abdel-Monem M M, Ohno K
J Pharm Sci. 1977 Aug;66(8):1195-7. doi: 10.1002/jps.2600660837.
TLC and high-pressure liquid chromatographic examination of the dansyl derivatives obtained from human urine indicated the presence of N-[3-[4-aminobutyl)amino]propyl]acetamide (N1-acetylspermidine), N-4-amino]buryl]acetamide (N8-acetylspermidine), N-(4-aminobutyl)acetamide (N-acetylputrescine), and N-(5-aminopentyl)acetamide (N-acetylcadaverine). The ratio of N1- to N8-acetylspermidine ranged from 10.3 in the urine of a patient with hepatoma to 1.1 in the urine of a normal subject. The three cancer patients had a considerably higher ratio of N1- to N8-acetylspermidine than did the three normal subjects. These findings indicate the ratio of N1- to N8-acetylspermidine in the 24-hr urine may serve as a biochemical marker for cancer.
对从人尿中获得的丹磺酰衍生物进行薄层色谱法(TLC)和高压液相色谱法检测,结果表明存在N-[3-[(4-氨基丁基)氨基]丙基]乙酰胺(N1-乙酰亚精胺)、N-[4-(3-氨基丙基)氨基]丁基]乙酰胺(N8-乙酰亚精胺)、N-(4-氨基丁基)乙酰胺(N-乙酰腐胺)和N-(5-氨基戊基)乙酰胺(N-乙酰尸胺)。N1-与N8-乙酰亚精胺的比例在肝癌患者尿液中为10.3,在正常受试者尿液中为1.1。三位癌症患者的N1-与N8-乙酰亚精胺比例明显高于三位正常受试者。这些发现表明,24小时尿液中N1-与N8-乙酰亚精胺的比例可能作为癌症的生化标志物。